(Photo: UNDP/Ferdinand Strobel)

Multi-Country Western Pacific Integrated HIV/tuberculosis (TB) Programme

The Multi-Country Western Pacific Integrated HIV/tuberculosis (TB) Programme is a three-year (2018-2020) US$11,368,713 programme supported by the Global Fund aiming to strengthen control of HIV and TB in 11 Pacific island countries: Cook Islands, Federated States of Micronesia, Kiribati, Nauru, Niue, Palau, Republic of Marshall Islands, Samoa, Tonga, Tuvalu and Vanuatu.

HIV prevalence in the 11 Western Pacific countries continues to be low, with overall prevalence estimated at 0.1 percent.1 The cumulative number of persons ever diagnosed with HIV up until 2015 in the programme supported countries is 223.2 Despite the low rates and numbers, HIV vulnerability is still high due to factors such as widespread migration and mobility, dense sexual networks, a large caseload of untreated sexually transmitted infections (STIs), low knowledge about HIV and STIs, high levels of transactional sex and significant levels of intimate partner violence.

To improve access to HIV care and diagnosis, community-based interventions are essential. HIV and STI services for key populations, including sex workers, men who have sex with men and transgender people, remain largely inadequate. Key populations are the most vulnerable and have limited access to prevention and diagnostic services due to stigma, discrimination and other social barriers. In 2016, a mapping and behavioural study among key populations was conducted in 9 of the 11 programme countries. The study revealed estimated populations of men who have sex with men and transgender people ranging from 20 (in Tuvalu) to 25,000 (in Samoa), and female sex workers from 10 (in Tuvalu) to 2,000 (in Vanuatu).3 The behavioural data showed widespread high risk behaviour, such as multiple sexual partners and unprotected sex, and low access to prevention and testing services.

In 2016, TB incidence rates across the 11 programme countries was 112 per 100,000 with total notified cases being 1,019. The incidence rates per country are: Kiribati (469), Republic of Marshall Islands (327), Tuvalu (198), Federated States of Micronesia (141), Palau (129), Nauru (93), Vanuatu (35), Cook Islands (13), Tonga (9), Samoa (7) and Niue (0). Countries are performing well with successful treatment rates averaging 84 percent. Prevalence of MDR-TB cases remains low with a total of 7 cases detected from 2014 to 2016,4 although this may increase with the universal use of GeneXpert machines in the countries. Similarly, cases of HIV-TB co-infection remain rare.

Despite achievements in the past decades, the TB mortality rate in the 11 programme countries is high with 17 per 100,000 population.5 The challenges, such as access to health services, insufficient quality of care and lack of financial and social protection, hamper further advancement of TB control. Formidable challenges must be overcome if the region is to become free from TB.
 

Objectives

  • Halt the spread of HIV among the populations and maintain HIV incidence rates below 0.1 percent annually;
  • Reduce AIDS-related mortality by strengthening HIV case finding and case management;
  • Reduce the prevalence, incidence and mortality from all forms of TB, thereby contributing to achieving the post-2015 global TB strategy; and
  • Promote universal and equitable access to quality diagnosis and appropriate treatment of TB, Multi-Drug Resistant (MDR) TB, TB-DM (diabetes mellitus) and people with HIV and TB coinfection.
     

Key activities

HIV:

  • Health systems and M&E: strengthening of routine reporting through the rapid assessment of information flows, updated guidelines and training manuals; technical assistance and capacity building.
  • Provision of antiretroviral (ARV) treatment to all people living with HIV.
  • Prevention of mother-to-child transmission (PMTCT): prevention of HIV infection among women of childbearing age; treatment, care and support to HIV positive mothers and their children.
  • Prevention programmes for MSM, transgender people, sex workers and their clients, and other vulnerable populations: provision of condoms and lubricants, behavioral change communication, HIV counselling and testing (HST), diagnosis and treatment of STIs, and small grant funds to finance and build capacity of key population groups.
  • Prevention programmes for the general population: condoms and lubricants; HCT; and diagnosis and treatment of STIs.
  • A small grants programme to support initiatives to address legal barriers and advocacy in participating countries. Activities will focus on addressing structural drivers of the HIV epidemic, including gender-based violence.
  • Advocacy programmes to address violence against women and girls.
  • Target groups include: men having sex with men, transgender people, sex workers, prisoners, seafarers, young people, people living with HIV or affected by HIV, people with STIs.

TB:

  • National level training in TB case management, including training on childhood TB, and the use of recording and reporting registers and forms.
  • Supporting TB screening and referral programmes for general and vulnerable groups and TB screening programmes for prison populations.
  • Implementing community outreach activities/programs with NGO partners and community members that target vulnerable groups.
  • Strengthening service delivery through training of health staff.
  • Harmonizing of TB recording and reporting (R&R) with National HMIS through development of electronic tools.
  • MDR TB second line drug procurement.
  • MDR help desk, supportive supervision and quality assurance.
  • Treatment support to HIV patients during course of TB treatment.
  • Training TB and HIV staff on TB/HIV collaborative activities.
  • Target groups include: people living with TB, household contacts of TB patients, prisoners, and health care providers and staff of TB control programmes.
     

Regional activities:

  • M&E systems strengthening, in collaboration with UNAIDS: targeting M&E people and data collection.
  • HIV Forum, in collaboration with FJN+: training for about 60 people living with HIV.
  • Regional meeting with country TB managers organized by WHO.
  • M-supply training for warehouse and lab staff.
  • TB clinicians refresher training.
  • TB lab refresher training.
  • Gender-based violence meeting/training.
     

Programme partners

Cook Islands: Cook Islands Ministry of Health

Federated States of Micronesia: Chuuk Women’s Council-FSM, Federated States of Micronesia Department of Health

Kiribati: Kiribati Ministry of Health

Republic of the Marshall Islands: Marshall Islands Ministry of Health

Nauru: Nauru Ministry of Health

Niue: Niue Ministry of Health

Palau: Palau Ministry of Health, PATLAB Initiatives members

Samoa: Samoa  Fa’afafine Association, Samoa Family Health Association, Samoa Ministry of Health

Tonga: Tonga Family Health Association, Tonga Letis Association, Tonga Ministry of Health

Tuvalu: Tuvalu Family Health Association, Tuvalu Ministry of Health

Vanuatu: Vanuatu Ministry of Health

Regional: Fiji Network for People Living with HIV/AIDS, The Pacific Sexual Diversity Network

Technical assistance: Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, World Health Organization

Principal recipient: United Nations Development Programme

 

Performance coverage indicators

 

Target 2018

Target 2019

Target 2020

Number of men who have sex with men reached with HIV prevention programmes

673

1,035

1,592

Number of men who have sex with men that have received an HIV test during the reporting period and know their results

289

445

685

Number of transgender people reached with HIV prevention programmes

1,345

2,070

3,185

Number of transgender people that have received an HIV test during the reporting period and know their results

995

1,532

2,357

Number of sex workers reached with HIV prevention programmes

283

435

670

Number of sex workers that have received an HIV test during the reporting period and know their results

269

413

637

Number of people living with HIV currently receiving antiretroviral therapy

58

68

79

Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse cases

1,253

 1,254

 1,266

Treatment success rate- all forms:  Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases

 86%

 87%

90%

Number of cases with RR-TB and/or MDR-TB that began second-line treatment

2

2

2

 

Budget by interventions

 

2018

2019

2020

Total

Comprehensive prevention programs for sex workers and their clients

$55,877

$42,503

$42,503

$140,884

Prevention programs for other vulnerable populations

$238,137

$243,128

$248,559

$729,825

Prevention programs for adolescents and youth, in and out of school

$49,189

$49,189

$49,189

$147,568

PMTCT

$16,832

$17,014

$17,202

$51,048

Treatment, care and support

$444,333

$347,953

$356,803

$1,149,089

TB care and prevention

$957,030

$1,026,965

$907,747

$2,891,742

TB/HIV

$207,099

$204,721

$244,993

$656,814

MDR-TB

$23,334

$48,334

$23,334

$95,001

Integrated service delivery and quality improvement

$43,660

$153,174

$43,660

$240,493

Human resources for health (HRH), including community health workers

$38,820

$38,820

$38,820

$116,459

Procurement and supply chain management systems

$40,000

$40,000

$40,000

$120,000

Community responses and systems

$89,735

$89,735

$89,735

$269,206

Health management information systems and M&E

$254,276

$136,067

$136,067

$526,411

Program management

$1,152,935

$1,136,417

$1,145,864

$3,435,217

Comprehensive prevention programs for TGs

$232,347

$118,435

$118,435

$469,217

Comprehensive prevention programs for MSM

$84,811

$71,437

$71,437

$227,686

Programs to reduce human rights-related barriers to HIV services

$102,053

 

 

$102,053

Total

$4,030,468

$3,763,894

$3,574,350

$11,368,713

 

Related documents

Follow Us

Status:

Ongoing

Project start date:

January 2018

Estimated end date:

December 2020

Focus area:

  • accelerate structural transformations
  • Project office:

    UNDP in Pacific Centre (PC)

    Implementing partner:

    United Nations Development Programme

    Full project information  

    Funding Support by

    Donor name

  • Global Fund To Fight Aids
  • Tuberculosis
  • Amount contributed

    $4,030,468

    Delivery in previous fiscal year

    2019 $3,090

    2018 $3,787,177

    UNDP Around the world

    You are at UNDP Pacific Office 
    Go to UNDP Global